Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo

Adam S Mastrocola1, Christopher D Heinen

  • 1Neag Comprehensive Cancer Center and Center for Molecular Medicine, University of Connecticut Health Center, Farmington, Connecticut 06030-3101, USA.

Human Mutation
|July 31, 2010
PubMed

Insights

Researchers developed new human cell models to assess DNA mismatch repair (MMR) gene MSH2 missense mutations. This aids in distinguishing pathogenic variants, crucial for Lynch Syndrome diagnosis and patient care.

Area of Science:

  • Genetics and Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • The DNA mismatch repair (MMR) pathway is critical for genomic stability and preventing cancer.
  • Loss of MMR function causes Lynch Syndrome (LS), a hereditary cancer predisposition.
  • MSH2 gene mutations are found in ~40% of LS patients, with 18% being missense variants.

Purpose of the Study:

  • To develop and utilize human cell models for functional analysis of MSH2 missense variants.
  • To improve the discrimination between pathogenic and benign MSH2 missense mutations.
  • To provide better tools for genetic counseling and patient management in Lynch Syndrome.

Main Methods:

  • Generated human cell lines stably expressing specific MSH2 missense mutants.
  • Assessed the impact of these mutants on DNA repair functions.
  • Evaluated the effect of mutants on DNA damage checkpoint response.

Main Results:

  • Demonstrated functional consequences of specific MSH2 missense alterations in human cells.
  • Provided a platform for expanded biochemical and functional analyses.
  • Expanded understanding of defects caused by single amino acid changes in MSH2.

Conclusions:

  • Functional characterization of MSH2 missense mutants in human cell models is essential.
  • Integrating functional data with clinical and biochemical information aids patient management.
  • Improved methods for variant classification are vital for Lynch Syndrome genetic counseling.